OKI THROAT * OS SPRAY 15ML 0.16%

OKI THROAT * OS SPRAY 15ML 0.16%

Therapeutic indications

Symptomatic treatment of irritative-inflammatory states also associated with oropharyngeal pain (eg gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.

Dosage and method of use

1-2 sprays up to 3 times a day, addressed directly to the affected area. Each spray delivers approximately 0.2 ml of solution, equivalent to 0.32 mg of active ingredient.

Contraindications

OKi throat 0.16% oral mucosal spray should not be administered in case of hypersensitivity to the active substance, to other non-steroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients, to patients in whom substances with a similar mechanism of action ( for example acetylsalicylic acid or other NSAIDs) cause asthma attacks, bronchospasm, acute rhinitis, or cause nasal polyps, hives or angioneurotic edema, in case of previous bronchial asthma, during pregnancy and lactation.

Side effects

Local side effects following topical administration on the oral mucosa of ketoprofen lysine salt solution are extremely rare and consist of irritative or allergic phenomena (angioneurotic edema) especially in subjects with hypersensitivity to NSAIDs. However, no systemic side effects emerged considering the route of administration and the dosage of drug administered.

Special warnings

The use, especially if prolonged, of topical drugs could give rise to sensitization phenomena, in which case it is necessary to suspend the treatment and adopt suitable therapeutic measures. The medicine contains methyl para-hydroxybenzoate, which is known to cause allergic reactions (including delayed).

Pregnancy and breastfeeding

As with other non-steroidal anti-inflammatory drugs, the product should not be used in case of known or suspected pregnancy and during breastfeeding.

Expiration and retention

No special instructions

Interactions with other drugs

At present there are no known interactions with other drugs: interactions that can also be excluded considering the route of administration and the dosage of drug administered.

Overdose

To date there are no known cases of overdose even considering the amount of active ingredient that would not make an accidental overdose possible.

Active principles

100 ml of oral mucosal spray contains as active ingredient: Ketoprofen lysine salt 0.16 grams corresponding to 0.10 grams of Ketoprofen For the full list of excipients, see section 6.1

Excipients

Glycerol 85%, xylitol, methyl para-hydroxybenzoate, monobasic sodium phosphate, poloxamer 407, mint flavor, ever cool flavor, purified water.